PLA2G4A and plasma cell myeloma: Moreover, high gene expression of PLA2G4A has been correlated with poor patient outcomes, e.g., relapse, development of metastasis and lower survival, in cancers of lung, liver, and breast, glioblastoma, and multiple myeloma [18,19,20,21,22].